Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

635
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
635
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

77
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
77
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

64
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
64
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

66
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
66
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

119
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
119
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

109
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
109

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Examining sex as a potential moderator of metacognitive training for psychosis efficacy on cognitive insight and jumping to conclusions bias: Evidence from a large-scale harmonized database.

Schizophrenia research. Cognition·2026
Same author

PERMEPSY: a multicentre, randomized, double-blind proof-of-concept trial of personalized metacognitive training for adults with psychosis - a study protocol.

Frontiers in psychiatry·2026
Same author

An Impact of Metacognitive Training and Cognitive-Behavioural Therapy on Quality of Life in Psychosis: A Systematic Review.

Clinical psychology & psychotherapy·2026
Same author

Machine Learning Prediction of Cardiovascular Risk in Type 1 Diabetes Mellitus Using Radiomic Features from Multimodal Retinal Images.

Ophthalmology science·2025
Same author

An artificial intelligence-based platform for personalized predictions of Metacognitive Training effectiveness.

Computational and structural biotechnology journal·2025
Same author

Dimensionality Reduction-Based Analysis of the Molecular Dynamics of G Protein-Coupled Receptors.

IEEE transactions on computational biology and bioinformatics·2025

相关实验视频

Updated: Jun 18, 2025

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.5K

使用可解释的机器学习模型理解药物概况的预测.

Caroline König1,2, Alfredo Vellido3,4

  • 1Intelligent Data Science and Artificial Intelligence (IDEAI-UPC) Research Centre, Universitat Politècnica de Catalunya (UPC Barcelona Tech), Jordi Girona 1-3, Barcelona, 08034, Catalonia, Spain. ckonig@cs.upc.edu.

BioData mining
|August 1, 2024
PubMed
概括

可解释的机器学习模型识别了影响吸收,分布,新陈代谢和分泌 (ADME) 属性的关键分子特征. 这有助于药物设计,揭示分子特征如何影响药物的有效性和选择.

关键词:
在ADME属性中,ADME的属性是:药物设计 药物设计可解释的机器学习分子描述器分子描述器

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K

相关实验视频

Last Updated: Jun 18, 2025

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.5K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K

科学领域:

  • 计算化学和化学信息学
  • 药理学和药物发现
  • 医学中的人工智能

背景情况:

  • 吸收,分布,新陈代谢和分泌 (ADME) 属性是药物的有效性和安全性的关键决定因素.
  • 在药物设计的早期预测ADME特性可以加速对可行的候选药物的鉴定.
  • 了解ADME的分子基础对于优化药物性能至关重要.

研究的目的:

  • 使用可解释的机器学习 (ML) 模型预测ADME的分子特性.
  • 识别和量化特定分子特征对ADME属性预测的影响.
  • 通过阐明分子特征对ADME行为的贡献来增强药物设计.

主要方法:

  • 使用可解释的机器学习 (ML) 模型进行ADME属性预测.
  • 采用特征排列技术来估计分子特征的相对重要性.
  • 应用SHAP (夏普利添加式扩展) 值来测量特征的个体影响.

主要成果:

  • 对每个ADME属性相关的特定分子描述符的识别.
  • 量化这些分子描述符对ADME属性预测准确度的影响.
  • 在预测ADME结果时显示特征的重要性.

结论:

  • 可解释的ML模型提供了对ADME预测分子特征贡献的详细见解.
  • 这些模型通过澄清分子特征的影响来支持药物候选人选择.
  • 该研究强调了可解释AI在推进制药研究中的实用性.